The DOI matches its Crossref record; 43 of the 44 references it cites were found in a registry or an index.
Inflammatory mechanisms linking obesity and metabolic disease
Open accessAbstract
There are currently over 1.9 billion people who are obese or overweight, leading to a rise in related health complications, including insulin resistance, type 2 diabetes, cardiovascular disease, liver disease, cancer, and neurodegeneration. The finding that obesity and metabolic disorder are accompanied by chronic low-grade inflammation has fundamentally changed our view of the underlying causes and progression of obesity and metabolic syndrome. We now know that an inflammatory program is activated early in adipose expansion and during chronic obesity, permanently skewing the immune system to a proinflammatory phenotype, and we are beginning to delineate the reciprocal influence of obesity and inflammation. Reviews in this series examine the activation of the innate and adaptive immune system in obesity; inflammation within diabetic islets, brain, liver, gut, and muscle; the role of inflammation in fibrosis and angiogenesis; the factors that contribute to the initiation of inflammation; and therapeutic approaches to modulate inflammation in the context of obesity and metabolic syndrome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This suggests that self-reported insomnia appears to result in a shift towards Th2 immunity”
From The Sleep-Immune Crosstalk in Health and Disease (2019) · cites this paper as [484]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inflammation and metabolic disorders
Hotamisligil, G. S. (2006) · Nature · doi:10.1038/nature05485 · Cited by 9,199
The metabolic phenotype in obesity: Fat mass, body fat distribution, and adipose tissue function
Goossens, G. H. (2017) · Obesity Facts · doi:10.1159/000471488 · Cited by 8,481
The global obesity pandemic: shaped by global drivers and local environments
Swinburn, B. A., Sacks, G., Hall, K. D., McPherson, K., Finegood, D. T., Moodie, M. L., & Gortmaker, S. L. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60813-1 · Cited by 4,888
Obesity induces a phenotypic switch in adipose tissue macrophage polarization
Lumeng, C. N., Bodzin, J. L., & Saltiel, A. R. (2007) · Journal of Clinical Investigation · doi:10.1172/jci29881 · Cited by 4,664
Self-citationMutation of the mouse klotho gene leads to a syndrome resembling ageing
Kuro-o, M., Matsumura, Y., Aizawa, H., Kawaguchi, H., Suga, T., Utsugi, T., Ohyama, Y., Kurabayashi, M., Kaname, T., Kume, E., et al. (1997) · Nature · doi:10.1038/36285 · Cited by 3,837
TLR4 links innate immunity and fatty acid-induced insulin resistance
Shi, H., Kokoeva, M. V., Inouye, K., Tzameli, I., Yin, H., & Flier, J. S. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28898 · Cited by 3,690
A central role for JNK in obesity and insulin resistance
Hirosumi, J., Tuncman, G., Chang, L., Görgün, C. Z., Uysal, K. T., Maeda, K., Karin, M., & Hotamisligil, G. S. (2002) · Nature · doi:10.1038/nature01137 · Cited by 3,359
Endoplasmic reticulum stress and the inflammatory basis of metabolic disease
Hotamisligil, G. S. (2010) · Cell · doi:10.1016/j.cell.2010.02.034 · Cited by 2,802
The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance
Vandanmagsar, B., Youm, Y.-H., Ravussin, A., Galgani, J. E., Stadler, K., Mynatt, R. L., Ravussin, E., Stephens, J. M., & Dixit, V. D. (2011) · Nature Medicine · doi:10.1038/nm.2279 · Cited by 2,655
Inflammatory links between obesity and metabolic disease
Lumeng, C. N., & Saltiel, A. R. (2011) · Journal of Clinical Investigation · doi:10.1172/jci57132 · Cited by 2,319
Self-citation
Flagged first, then by citations
1 of the 44 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 901–1,000 of 1,002
pre-existing diabetes and PTDM in kidney transplant recipients: how to handle immunosuppression
Chevallier, E., Jouvé, T., Rostaing, L. P. E., Malvezzi, P., & Noble, J. (2020) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2021.1851596 · Cited by 13
Inflammation Precedes Fat Deposition in an Experimental Model of Lymphedema
Cuadrado, G. D. A., Andrade, M., Ariga, S. K. K., de Lima, T. M., & de Souza, H. P. (2020) · Lymphatic Research and Biology · doi:10.1089/lrb.2020.0061 · Cited by 13
Mitohormesis; Potential implications in neurodegenerative diseases
Gohel, D., & Singh, R. K. (2020) · Mitochondrion · doi:10.1016/j.mito.2020.11.011 · Cited by 14
New insights into BMP9 signaling in liver diseases
Jiang, Q., Liu, B., & Xu, K. (2021) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-021-04182-6 · Cited by 14
“1 3 of proinflammatory adipokines from WAT due to obesitymediated dysfunction has been reported to cause IR and T2DM [44, 45].”
BackgroundPetito, G., Cioffi, F., Silvestri, E., Matteis, R. D., Lattanzi, D., de Lange, P., Lombardi, A., Moreno, M., Goglia, F., Lanni, A., et al. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.703170 · Cited by 14
Jiao, X., Shen, Y., Deng, H., Zhang, Q., & Zhao, J. (2021) · Journal of Functional Foods · doi:10.1016/j.jff.2021.104616 · Cited by 14
Severi, I., Fosca, M., Colleluori, G., Marini, F., Imperatori, L., Senzacqua, M., Vincenzo, A. D., Barbatelli, G., Fiori, F., Rau, J. V., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22158049 · Cited by 14
“The impaired glucolipid profile induced by obesity is associated with both inflammation and cellular toxicity [4,5,8], with some tissues being affected earlier than others.”
BackgroundAdipose-derived stem cells and obesity: The spear and shield relationship
Yang, H., Li, C., Li, Y., Tai, R., & Sun, C. (2021) · Genes & Diseases · doi:10.1016/j.gendis.2021.09.004 · Cited by 15
Estrogen Impairs Adipose Tissue Expansion and Cardiometabolic Profile in Obese-Diabetic Female Rats
Martínez-Cignoni, M. R., González-Vicens, A., Morán-Costoya, A., Proenza, A. M., Gianotti, M., Valle, A., & Lladó, I. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222413573 · Cited by 14
“Chronic inflammation in WAT may cause whole-body insulin resistance in obese-diabetic animals [38,39].”
BackgroundRho/ROCK mechanosensor in adipocyte stiffness and traction force generation
Bouzid, T., Esfahani, A. M., Safa, B. T., Kim, E., Saraswathi, V., Kim, J. K., Yang, R., & Lim, J. Y. (2022) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2022.03.078 · Cited by 14
Zhang, W., Wang, W., Li, L., Miller, M. R., Cui, L., Liu, J., Wang, Y., Hu, D., Liu, S., Xu, J., et al. (2022) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2022.159014 · Cited by 14
Asperlin Stimulates Energy Expenditure and Modulates Gut Microbiota in HFD-Fed Mice
Wu, C., Zhou, Y., Qi, G., Liu, D., Cao, X., Yu, J., Zhang, R., Lin, W., & Guo, P. (2019) · Marine Drugs · doi:10.3390/md17010038 · Cited by 15
“9 billion people being obese or overweight [1].”
BackgroundAspects of the immune system that impact brain function
Bondy, S. C. (2020) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2020.577167 · Cited by 14
Association between the IL-6, IL-10, and TNFα gene polymorphisms and preterm-birth in Korean women
Han, S. H., Lee, N. R., Kim, H. J., Kang, Y. D., Kim, J. S., Park, J. W., & Jin, H. J. (2020) · Genes & Genomics · doi:10.1007/s13258-020-00946-4 · Cited by 14
Get in Touch With Dendritic Epithelial T Cells!
Thelen, F., & Witherden, D. A. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01656 · Cited by 14
MicroRNA Expression Profiles in the Subcutaneous Adipose Tissues of Morbidly Obese Chinese Women
Wang, L., Chen, S., Pan, H., Yang, H., Zhu, H., & Gong, F. (2021) · Obesity Facts · doi:10.1159/000511772 · Cited by 14
Subramanian, G., Shanmugamprema, D., Subramani, R., Muthuswamy, K., Ponnusamy, V., Tankay, K., Velusamy, T., Vasanth, K., & Selvakumar, S. (2021) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202001224 · Cited by 14
Macrophage-derived extracellular vesicles as new players in chronic non-communicable diseases
Lin, F., Luo, H., Wang, J., Li, Q., & Zha, L. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1479330 · Cited by 13
Jayaraj, K., Kumar, R. N., Shyamasundar, S., Arumugam, T. V., Polepalli, J. S., & Dheen, S. T. (2025) · Glia · doi:10.1002/glia.70035 · Cited by 14
Telomere length is maternally inherited and associated with lipid metabolism in Chinese population
Guo, L., Chen, Y., Li, H., Yin, F., Ge, M., Li, H., Zi, M., Qin, Z., & He, Y. (2022) · Aging · doi:10.18632/aging.203810 · Cited by 13
“Moreover, obesity is a key factor in the development of metabolic abnormalities [51], including metabolic syndrome, systemic chronic inflammation and oxidative stress.”
BackgroundSearching for the Optimal Donor for Allogenic Adipose-Derived Stem Cells: A Comprehensive Review
Georgiev-Hristov, T., García‐Arranz, M., Trébol, J., Recreo, P. B., & García‐Olmo, D. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14112338 · Cited by 13
“Obesity is a well-known proinflammatory state [31].”
Kobayashi, G., Okada, H., Hamaguchi, M., Kurogi, K., Murata, H., Ito, M., & Fukui, M. (2022) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2022.110179 · Cited by 13
Park, S., Kang, D. Y., Ahn, H., Kim, N., Yoon, J., & Yang, B. R. (2022) · Scientific Reports · doi:10.1038/s41598-022-25787-x · Cited by 13
Su, L.-Y., Huang, W.-C., Kan, N., Tung, T.-H., Huynh, L. B. P., & Huang, S. (2023) · Nutrients · doi:10.3390/nu15010249 · Cited by 14
“Increased levels of IL-6 and TNF-α in adipose tissue have been observed in individuals with obesity during long-duration eccentric contraction exercise [7]; however, the related cytokine mechanism is not understood.”
BackgroundTibetan tea reduces obesity brought on by a high‐fat diet and modulates gut flora in mice
He, G., Chen, T., Huang, L., Zhang, Y., Feng, Y., Liu, Q., Yin, X., Qu, S., Yang, C. C., Wan, J., et al. (2023) · Food Science & Nutrition · doi:10.1002/fsn3.3607 · Cited by 13
“However, it is also linked to problems with lipid and blood glucose metabolism, chronic inflammation, and a higher risk of many illnesses, including type 2 diabetes, hypertension, and cancer (Saltiel & Olefsky, 2017).”
Huang, J., Gao, T., Zhang, H., & Wang, X. (2023) · Scientific Reports · doi:10.1038/s41598-023-43028-7 · Cited by 13
Xia, X., Chen, S., Tian, X., Xu, Q., Zhang, Y., Zhang, X., Li, J., Wang, P., Wu, S., & Wang, A. (2023) · Endocrine · doi:10.1007/s12020-023-03570-w · Cited by 13
de Melo, D. G., Rodrigues, V. C. D. C., Pereira, G. J. D. S., de Campos, T. D. P., Canciglieri, R. D. S., Pauli, J. R., da Silva, A. S. R., Fernandes, C. J. D. C., & de Moura, L. P. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.122567 · Cited by 13
Extracellular vesicles released from microglia after palmitate exposure impact brain function
de Paula, G. C., Aldana, B. I., Battistella, R., Fernández‐Calle, R., Bjure, A., Lundgaard, I., Deierborg, T., & Duarte, J. M. N. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03168-7 · Cited by 15
“…saturated fat exposure is known to stimulate NF-κB transcriptional activity and the secretion of pro-inflammatory mediators in peripheral organs, such as liver, white adipose tissue, and leukocytes [44], In the brain, the neuroinflammatory process in DIO remains unclear, and somehow controversial.”
BackgroundSchleh, M. W., Ameka, M., Rodriguez, A. S., & Hasty, A. H. (2024) · Diabetes · doi:10.2337/db24-0405 · Cited by 13
Molecular mechanisms of obesity predisposes to atopic dermatitis
Shang, D., & Zhao, S. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1473105 · Cited by 16
Pyrroloquinoline quinone attenuates obesity associated low grade inflammation
Devasani, K., & Majumdar, A. S. (2019) · Obesity Medicine · doi:10.1016/j.obmed.2019.100134 · Cited by 13
Yang, P., Yamaki, M., Kuwabara, S., Kajiwara, R., & Itoh, M. (2019) · Experimental Gerontology · doi:10.1016/j.exger.2019.110720 · Cited by 13
Intricate interplay between Covid‐19 and cardiovascular diseases
Keri, V. C., Hooda, A., Kodan, P., Brunda, R. L., Jorwal, P., & Wig, N. (2020) · Reviews in Medical Virology · doi:10.1002/rmv.2188 · Cited by 13
Yang, F., Cai, H.-H., Zhang, X., Sun, J., Feng, X., Yuan, H., Zhang, X., Xiao, B., & Li, Q. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.107676 · Cited by 13
SARS-CoV-2-associated gut microbiome alteration; A new contributor to colorectal cancer pathogenesis
Mozaffari, S. A., Salehi, A., Mousavi, E., Zaman, B. A., Nassaj, A. E., Ebrahimzadeh, F., Nasiri, H., Valedkarimi, Z., Adili, A., Asemani, G., et al. (2022) · Pathology - Research and Practice · doi:10.1016/j.prp.2022.154131 · Cited by 13
“tion during acute infection [103] and can trigger chronic diseases, such as malignancies [104].”
BackgroundCastaño, C., Novials, A., & Párrizas, M. (2022) · Cells · doi:10.3390/cells12010169 · Cited by 14
“Keywords: exosome; miRNA; obesity; MAFLD; biomarker”
BackgroundInfluentialShin, Y.-E., Choi, J., Park, Y. I., & Kim, H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043520 · Cited by 13
Christakoudi, S., Tsilidis, K. K., Εvangelou, Ε., & Ríboli, E. (2023) · Biology of Sex Differences · doi:10.1186/s13293-023-00494-y · Cited by 15
“Background Obesity is associated with chronic low-grade inflammation and a higher risk of venous thromboembolism [1, 2] and contributes to the development of cardiovascular diseases and some cancers [3, 4].”
BackgroundAlmajwal, A. M., Alam, I., Zeb, F., & Fatima, S. (2019) · Food and Nutrition Sciences · doi:10.4236/fns.2019.101006 · Cited by 12
“A few examples are diabetes mellitus [21] [22], obesity [23], sepsis [24], different types of arthritis (including rheumatoid arthritis) [25], systemic lupus erythematosus [26], ankylosing spondylitis [27], trauma [28], painful states such as postoperative pain [29], migraine [30], schizophrenia [31], major depression…”
BackgroundWalker, M. E., Matthan, N. R., Goldbaum, A. A., Meng, H., Lamon‐Fava, S., Lakshman, S., Jang, S., Molokin, A., Solano-Aguilar, G. I., Urban, J. F., et al. (2019) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2019.04.013 · Cited by 13
“Chronic low-grade inflammation is thought to be a key mediator in the association between obesity and the development of cardiometabolic diseases [1].”
BackgroundDentz, K. E. V., Silva, B. S., de Queiroz, E. A. I. F., Bomfim, G. F., do Nascimento, A. F., Sugizaki, M. M., & Luvizotto, R. D. A. M. (2020) · Nutrition & Food Science · doi:10.1108/nfs-03-2020-0092 · Cited by 14
Key Metabolic Functions of β-Arrestins: Studies with Novel Mouse Models
Pydi, S. P., Barella, L. F., Meister, J., & Wess, J. (2020) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2020.11.008 · Cited by 15
Ying, L., Zhang, M., Ma, X., Si, Y., Li, X., Su, J., Yin, J., & Bao, Y. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.672032 · Cited by 13
“This is accompanied by the activation of macrophages and the increase of pro-inflammatory cytokines (Shoelson et al., 2006; Pellicoro et al., 2014; Tomita et al., 2014; Saltiel and Olefsky, 2017), suggesting a role of macrophages in the development of obesity and metabolic disorders.”
BackgroundEditorial: Advances in Osteoimmunology
Blin‐Wakkach, C., & de Vries, T. J. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02595 · Cited by 13
“Obesity is a growing health care concern in Western society, a condition associated with an altered immune system (10, 11).”
BackgroundRigamonti, A. E., Cicolini, S., Tamini, S., Caroli, D., Cella, S. G., & Sartorio, A. (2021) · International Journal of Endocrinology · doi:10.1155/2021/5576286 · Cited by 13
“Metabolic syndrome is a condition evolving over time, with a progressive increase in the number of cardiovascular risk factors in parallel with the natural history of the obese state, characterized by low-grade chronic inflammation, accelerated aging, and metabolic dysregulation [12].”
BackgroundRocha, A. R. D. F., de Morais, N. D. S., Azevedo, F. M., Morais, D. D. C., Pereira, P. F., Pelúzio, M. D. C. G., Franceschini, S. D. C. C., & Priore, S. E. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1560080 · Cited by 13
The complicated relationship between inflammation and metabolic dysfunction
Abtin, S., Ziveh, T., & Rezaee-Tavirani, M. (2025) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-025-01729-y · Cited by 15
“This review examines key issues, including the impact of the gut microbiome, societal factors, chronic stress and depression, and the aging process.”
Macrophage Phenotypic Switch and Obesity‐Associated Metabolic Risk: Mechanisms and Targets
Vera, K., Hemakumar, C., Bilachi, R. S., Ramírez, D. C., & Gomez-Mejiba, S. (2025) · Oxidative Medicine and Cellular Longevity · doi:10.1155/omcl/6710641 · Cited by 12
Lo, P., Yao, Y., & Zhou, Q. Y. (2020) · Cancers · doi:10.3390/cancers12082235 · Cited by 12
Ludzki, A. C., Schleh, M. W., Krueger, E. M., Taylor, N., Ryan, B. J., Baldwin, T. C., Gillen, J. B., Ahn, C., Varshney, P. K., & Horowitz, J. F. (2021) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00943.2020 · Cited by 12
Satô, A., Suzuki, S., Yuan, H., Fahreza, R. R., Wang, X., Nemoto, E., Saito, M., & Yamada, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24020970 · Cited by 14
Zhang, W., Jia, X., Xu, Y., Xie, Q., Zhu, M., Zhao, Z., Hao, J., Li, H., Du, J., Liu, Y., et al. (2023) · Journal of Food Science · doi:10.1111/1750-3841.16474 · Cited by 13
“Obesity increases the endoplasmic reticulum stress and activates the unfolded protein response, which in turn triggers NF-κ B, JNK, and other pathways and increases oxidative stress, thereby upregulating the inflammatory cytokines (Saltiel & Olefsky, 2017).”
Weng, X., Liu, S., Li, M., Zhang, Y., Zhang, Y., Liu, C., Zhu, J., & Hu, H. (2023) · Psychogeriatrics · doi:10.1111/psyg.13015 · Cited by 13
Kobayashi, Y., Eguchi, A., Imami, K., Tempaku, M., Izuoka, K., Takase, T., Kainuma, K., Nagao, M., Furuta, N., Iwasa, M., et al. (2023) · Journal of Molecular Medicine · doi:10.1007/s00109-023-02386-5 · Cited by 15
Wang, Q., Tang, X., Wang, Y., Zhang, D.-Y., Li, X., & Liu, S. (2024) · Journal of Advanced Research · doi:10.1016/j.jare.2024.03.009 · Cited by 12
Chianelli, M., Armellini, M., Carpentieri, M. S., Coccaro, C., Cuttica, C. M., Fusco, A., Marucci, S., Nelva, A., Nizzoli, M., Ponziani, M. C., et al. (2024) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/0118715303282327240507184902 · Cited by 14
Kim, J.-H., Baek, J.-Y., Han, K., Kim, B.-S., & Kwon, H.-S. (2024) · Journal of Shoulder and Elbow Surgery · doi:10.1016/j.jse.2024.03.063 · Cited by 12
Xu, M.-R., Wang, A.-P., Wang, Y., Lu, J., Shen, L., & Li, L. (2024) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2023.0401 · Cited by 12
Samanta, S., Bagchi, D., & Bagchi, M. (2024) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-024-01040-z · Cited by 18
“It was reported that obese individuals and type 2 diabetic patients exhibited adipose tissue inflammation, and they had increased levels of cytokines [ 54, 68 , 94 ].”
Liang, Y., Liu, Y., Tan, Q., Zhou, K., Wu, Y., & Li, Y. (2024) · Lipids in Health and Disease · doi:10.1186/s12944-024-02339-y · Cited by 13
“Additionally, metabolic syndrome, stemming from obesity, is characterized by mild chronic inflammation closely associated with metabolic disorders, including insulin resistance, diabetes, hypertension, and lipid metabolism disorders [20, 21].”
BackgroundMetz, C. N., Xue, X., Chatterjee, P. K., Adelson, R. P., Roth, J., Brines, M. L., Tracey, K. J., Gregersen, P. K., & Pavlov, V. A. (2025) · BMC Women s Health · doi:10.1186/s12905-025-03588-4 · Cited by 16
Teruya, H., Shoda, H., Itamiya, T., Tsuchida, Y., Okamura, T., & Fujio, K. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1503559 · Cited by 12
Denisova, T., Ivanovna, G. L., Pakhmutova, N. L., Mahesh, S., & Vithoulkas, G. (2018) · American Journal of Case Reports · doi:10.12659/ajcr.913328 · Cited by 12
“It has been suggested that a patient’s immune system has a major role to play in the onset and maintenance of obesity and its complications [2].”
BackgroundSingle cell sequencing unraveling genetic basis of severe COVID19 in obesity
AbdelMassih, A. F., Fouda, R., Kamel, A., Mishriky, F., Ismail, H., Qadi, L. E., Malak, L., Mohamed, M. M., Arsanyous, M. B., Hazem, M., et al. (2020) · Obesity Medicine · doi:10.1016/j.obmed.2020.100303 · Cited by 14
Effects of PCB126 on Adipose-to-Muscle Communication in an in Vitro Model
Caron, A., Ahmed, F., Peshdary, V., Garneau, L., Atlas, E., & Aguer, C. (2020) · Environmental Health Perspectives · doi:10.1289/ehp7058 · Cited by 12
“One player in adipose-to-muscle communication is an altered secretion of fatty acids by adipose tissue (Rachek 2014), which might be promoted by PCB exposure (Regnier and Sargis 2014) or insulin resistance.”
BackgroundZhou, Y., Takano, T., Wang, Y., Li, X., Wang, R., Wakatsuki, Y., Nakajima‐Adachi, H., Tanokura, M., Miyakawa, T., & Hachimura, S. (2020) · iScience · doi:10.1016/j.isci.2020.101883 · Cited by 12
“INTRODUCTION In 2006, Hotamisgil originally summarized the concept of ‘‘metabolically triggered inflammation (metainflammation)’’, which is a long-term, low-grade, chronic persistent inflammation caused by overnutrition or metabolic load (Hotamisligil, 2006; Saltiel and Olefsky, 2017).”
BackgroundLi, F., Wang, S., Chen, F., Zhang, C., Wang, Q., Zhao, Y., & Zhang, Z. (2021) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s299570 · Cited by 12
“It has been well established that chronic low-grade inflammation plays a pivotal role in the development and progression of metabolic diseases.(53) Thus, hepatic ETAR knockdown may ameliorate metabolic disorders via restraining oxidative stressinflammatory signaling.”
BackgroundZhang, Y., Jin, W., Zhang, D., Lin, C., He, H., Xie, F., Gan, L., Fu, W., Wu, L., & Wu, Y. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/9142798 · Cited by 12
“Both obesity and T2DM have been considered as a chronic low-grade inflammatory [38].”
Perugini, J., Mercurio, E. D., Giuliani, A., Sabbatinelli, J., Bonfigli, A. R., Tortato, E., Severi, I., Cinti, S., Olivieri, F., le Roux, C. W., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-11942-x · Cited by 17
Monserrat-Mesquida, M., Quetglas‐Llabrés, M. M., Bouzas, C., García, S., Mateos, D., Gómez, C., Gámez, J. M., Poulsen, H. E., Tur, J. A., & Sureda, A. (2022) · Antioxidants · doi:10.3390/antiox11071326 · Cited by 14
“The activation of these pathways, in turn, induces the secretion of chemokines such as monocyte chemoattractant protein-1 (MCP1), increasing the infiltration of proinflammatory macrophages to hepatocytes or adipocytes [15].”
BackgroundZhao, Y., Xiang, Q., Lin, J., Jiang, S., & Li, W. (2022) · Frontiers in Surgery · doi:10.3389/fsurg.2022.941672 · Cited by 13
“Although previous studies indicated that a high BMI or obesity is involved in the pathology of several human diseases, such as tumors, diabetes, and cardiovascular diseases (28, 29), the underlying mechanism of a high BMI or obesity contributing to the pathogenesis of OSL remains unclear to date (12, 30).”
Li, G., Li, S., Liu, H., Zhang, L., Gao, J., Zhang, S., Zou, Y., Xia, X., & Ren, X. (2022) · Nutrients · doi:10.3390/nu14193928 · Cited by 12
“The inflammatory program, activated at the onset of adipose tissue expansion and subsequently in chronic obesity, continually shifts the immune system to a pro-inflammatory phenotype [35].”
BackgroundWu, C., Qiu, T., Yuan, W., Shi, Y., Yao, X., Jiang, L., Zhang, J., Yang, G., Liu, X., Bai, J., et al. (2022) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2022.103981 · Cited by 12
Li, T., Qu, J., Xu, C., Fang, T., Sun, B., & Chen, L. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1072955 · Cited by 12
“Meanwhile, the mitochondrial impairment of obesity is able to stimulate the production of reactive ROS further to promote inflammation, thereby accelerating Alzheimer’s disease progression (45).”
BackgroundLiu, S., Liu, K., Wang, Y., Wu, C., Xiao, Y., Liu, S., Yu, J., Ma, Z., Liang, H., Li, X., et al. (2022) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2022.166620 · Cited by 12
Christakoudi, S., Tsilidis, K. K., Εvangelou, Ε., & Ríboli, E. (2023) · BMC Endocrine Disorders · doi:10.1186/s12902-023-01423-1 · Cited by 12
“Obesity represents a state of chronic low-grade inflammation and increases the risk of type 2 diabetes mellitus [2].”
BackgroundPark, K.-A., Jin, Z. H., An, H. S., Lee, J. Y., Jeong, E. A., Choi, E. B., Kim, K. E., Shin, H. J., Lee, J. E., & Roh, G. S. (2019) · Korean Journal of Physiology and Pharmacology · doi:10.4196/kjpp.2019.23.5.335 · Cited by 12
Alexandersson, I., Harms, M. J., & Boucher, J. (2020) · Journal of Visualized Experiments · doi:10.3791/60485 · Cited by 12
Ahn, Y. J., Wang, L., Foster, S., & Asmis, R. (2020) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2020.108483 · Cited by 12
Sun, N., Meng, F., Zhao, J., Li, X., Li, R., Han, J. D. J., Chen, X., Cheng, W., Yang, X., Kou, Y., et al. (2021) · International Journal of Biological Sciences · doi:10.7150/ijbs.56477 · Cited by 12
“From a public health perspective, obesity is a major risk factor for cancers and metabolic disorders, including nonalcoholic fatty liver disease, diabetes, and cardiovascular disease [2-5].”
BackgroundDiet and Hygiene in Modulating Autoimmunity During the Pandemic Era
Abdelhamid, L., & Luo, X. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2021.749774 · Cited by 12
Svensson, H. G., Einarsson, S., Olausson, D., Kluge, L., Bergh, C., Edén, S., Lönn, M., & Thurin‐Kjellberg, A. (2022) · Scientific Reports · doi:10.1038/s41598-022-17612-2 · Cited by 13
Skin metabolism in obesity: A narrative review
Zaccaron, R. P., Mendes, C., da Costa, C., Silveira, P. C. L., & Rezin, G. T. (2024) · Wound Repair and Regeneration · doi:10.1111/wrr.13223 · Cited by 12
“16 Initially, a physiological inflammatory condition is triggered and pro-inflammatory markers are released to promote the remodelling of adipose deposits to accommodate more triglycerides.”
Wang, J., He, Y., Kim, A.-R., Lee, K.-H., & Choi, S. W. (2025) · Journal of Sports Sciences · doi:10.1080/02640414.2025.2486886 · Cited by 12
“Moreover, obesity increases the total number of macrophages, and chronic obesity-related inflammation promotes a phenotypic shift in macrophages from the M2 (anti-inflammatory) type to the M1 (pro-inflammatory) type (Saltiel & Olefsky, 2017).”
Lü, L., Chen, X., Liou, S., & Weng, X. (2025) · Journal of Health Population and Nutrition · doi:10.1186/s41043-025-01039-2 · Cited by 19
“In addition, low-grade inflammation may trigger these metabolic abnormalities [5, 6].”
Mashayekhi, M., Wanjalla, C. N., Warren, C. M., Simmons, J. D., Ghoshal, K., Pilkinton, M. A., Bailin, S. S., Gabriel, C. L., Pozzi, A., Koethe, J. R., et al. (2021) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2021.106604 · Cited by 12
BMI and Cardiometabolic Traits in Japanese: A Mendelian Randomization Study
Nagayoshi, M., Hishida, A., Shimizu, T., Kato, Y., Kubo, Y., Okada, R., Tamura, T., Otonari, J., Ikezaki, H., Hara, M., et al. (2023) · Journal of Epidemiology · doi:10.2188/jea.je20220154 · Cited by 12
Xu, R., Zhao, H., Qi, J., Yao, G., He, Y., Lu, Y., Zhu, Q., Wang, Y., Ding, Y., Zhu, Z., et al. (2022) · The FASEB Journal · doi:10.1096/fj.202201796rr · Cited by 11
Association between Shift Work and Metabolic Syndrome: A 4-Year Retrospective Cohort Study
Ye, B. (2023) · Healthcare · doi:10.3390/healthcare11060802 · Cited by 11
Cui, F., Sun, J. Y., Mi, H., Li, B., Tang, L., Wang, R., Du, Y., Guo, B., Li, Y., & Shi, M. (2023) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2023.127259 · Cited by 11
Zhang, B., Zhu, G., Liu, J., Zhang, C., Ke, Y., Huang, X., Cen, X. B., & Zhao, Z. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.110715 · Cited by 11
Relationship of serum 25-hydroxyvitamin D, obesity with new-onset obstructive sleep apnea
Zhang, Y., Zhang, Y., Ye, Z., Zhou, C., Yang, S., Liu, M., He, P., Gan, X., & Qin, X. (2023) · International Journal of Obesity · doi:10.1038/s41366-023-01402-5 · Cited by 11
Huo, J., Xu, Y., Yu, J., Guo, Y., Hu, X., Ou, D., Qu, R., & Zhao, L. (2023) · European journal of medical research · doi:10.1186/s40001-023-01480-1 · Cited by 13
“Adipocytes can also recruit and activate immune cells, promoting the release of pro-inflammatory mediators, and contributing to the development of chronic inflammatory conditions [16, 17].”
BackgroundYang, H., Li, C., Che, M., Liang, J., Tian, X., Yang, G., & Sun, C. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.128852 · Cited by 11
The BET inhibitor JQ1 targets fat metabolism and counteracts obesity
Fornelli, C., Cento, A. S., Nevi, L., Mastrocola, R., Alves, G. F., Caretti, G., Collino, M., & Penna, F. (2024) · Journal of Advanced Research · doi:10.1016/j.jare.2024.02.001 · Cited by 14
Comparison of the gastrointestinal bacterial microbiota between dairy cows with and without mastitis
Guo, C., Liu, J., Wei, Y., Du, W., & Li, S. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1332497 · Cited by 14
Rendón-Marín, S., & Ruíz-Saenz, J. (2024) · Scientific Reports · doi:10.1038/s41598-024-67781-5 · Cited by 11
Zhou, Y., Xie, Y., Dong, J., & He, K. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1445395 · Cited by 12
Metadata
- Authors
- Saltiel, A. R., & Olefsky, J. M.
- Affiliations
- University of California San Diego (US)
- Venue
- Journal of Clinical Investigation
- Published
- 2017-01-03
- Volume
- 127
- Issue
- 1
- Pages
- 1-4
- ISSN
- 0021-9738 (ISSN-L)
- 1558-8238
- PMC
- PMC5199709
- OpenAlex
- W2567264284
- Cited by
- 2,212
- References
- 44
- Citations by year
- 2026: 261 · 2025: 318 · 2024: 265 · 2023: 255 · 2022: 308 · 2021: 280 · 2020: 270 · 2019: 136 · 2018: 80 · 2017: 36
- FWCI
- 18.93
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- University of California, San Diego (P30DK063491, DK063491)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK063491, P30DK063491)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Disease and Adiposity
- Keywords
- obesity, metabolic syndrome, low-grade inflammation, insulin resistance, type 2 diabetes, adipose tissue expansion, innate immune system, adaptive immunity, neuroinflammation, liver inflammation, intestinal inflammation, skeletal muscle inflammation, fibrosis, angiogenesis, anti-inflammatory therapy
- MeSH terms
- Animals, Cardiovascular Diseases, Diabetes Mellitus, Type 2, Humans, Inflammation, Neoplasms, Obesity, Organ Specificity, Neurodegenerative Diseases, Metabolic Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
